Is Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s patent grant rate increasing or decreasing?

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s recent grant velocity is +29% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s patents?

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s patents average 11.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)

Q: Where does Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) ranks #835 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 545 granted patents across 72 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inserm ranks #835 of 49,997 tracked US assignees by granted-patent volume, with 545 patents across 72 technology areas.

#835
of 49,997 US assignees by volume: Top 5%
by Innovation Score (58.2/100): 11.0
avg claims per patent: +29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R835 · Foreign Corporation #835 · 545 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MID 545 grants
TOP-DECILE #835/49,997
PHOTO-FINISH Alps Alpine
CPC-WIDE A61K · 72 areas
INNOV-PAR 58.2/100
CLAIMS-PAR 11.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alps Alpine Co., Ltd. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Ajou University… · near

58
Beijing University… · near

58
Inserm (INSTITUT… · this assignee

58
John Bean · near

58
Littelfuse · near

58
3D Lighting… · lowest

7

What this shows Inserm's Innovation Score is 58.2/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Inserm's grant cadence moved

Between 2020–2024, Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) received 288 grants versus 223 in 2015–2019 (+29% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 76 grants and bottomed in 2015 at 28. Lead class A61K accounts for 65.1% of the portfolio across 72 subclasses. Volume neighbours: Walters Gardens, Inc. (#831) and Digimarc Corporation (#839).

Inserm's three-year grant acceleration

From 2019–2021 to 2022–2024, Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) moved from 204 to 149 grants (0.73x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,055. See the growth leaderboard.

Walters Gardens

554
Lapis Semiconduct…

552
Gree Holdings

549
Alps Alpine

546
Inserm (Institut… ◀

545
Max-planck-gesell…

544
Aisin

543
Delta (Shanghai)

543
Digimarc

543

What this shows Inserm holds 545 patents at rank #835, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inserm

By rank, the assignees closest to #835 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Inserm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Inserm, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (58 here).

Littelfuse, Inc. 58 Ajou University Industry-academic Cooperation 58 Beijing University OF Posts AND Telecommunications 58 John Bean Technologies Corporation 58

Similar claim depth

Nearest assignees by average claims per patent (11.0 here).

Stolle Machinery Company, LLC 11.0 avg Albea Services 11.0 avg Nicoventures Holdings Limited 11.0 avg Sotera Wireless, Inc. 11.0 avg

Inserm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	28	5.1%
2016	35	6.4%
2017	44	8.1%
2018	51	9.4%
2019	65	11.9%
2020	76	13.9%
2021	63	11.6%
2022	65	11.9%
2023	38	7.0%
2024	46	8.4%
2025partial year	34	6.2%

Which technologies does Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 355

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 343

C07K - Peptides 216

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 157

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 136

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 67

A61B - DIAGNOSIS; SURGERY; Identification 34

Y02A - Technologies FOR Adaptation TO Climate Change 27

C12Y - Enzymes 26

C07D - Heterocyclic Compounds 25

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 16

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 14

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 12

C07C - Acyclic OR Carbocyclic Compounds 11

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 10

Top 15 of 72 technology areas

Where it ranks

Overall rank by patents

#835

of 49,997 tracked assignees

Innovation Score

58.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s patent record in context - here's where to go next.

Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE)'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 65.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #835 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inserm (INSTITUT National DE LA SANTÉ ET DE LA Recherche MÉDICALE) against Walters Gardens, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 58.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.